Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2019-12-13 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于公司及控股子公司2020年度向银行申请授信额度及担保事项的公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement from Huabang Life Health Co., Ltd. regarding the company's and its subsidiaries' application for bank credit limits and guarantee matters for the year 2020. It includes extensive information about the credit limits, guarantee amounts, the purpose of the credit, details of subsidiaries involved, financial data of these subsidiaries, and the board and independent directors' opinions on the matter. The document is not a financial report like an annual or interim report, nor is it a transcript, audit report, or earnings release. It is a formal announcement about financing activities, specifically about credit and guarantee applications to banks. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document is lengthy and substantive, not a mere announcement of a report publication or a regulatory filing. Therefore, the correct classification is CAP.
2019-12-13 Chinese
关于预计2020年度开展远期结售汇业务和人民币对外汇期权组合等业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Huabang Life Health Co., Ltd. regarding the company's plan to conduct forward foreign exchange settlement and RMB foreign exchange option combination businesses in 2020. It details the purpose, business nature, currency involved, transaction scale, risk analysis, and risk control measures related to these foreign exchange derivative activities. The document is a formal public announcement made by the board of directors and includes references to regulatory compliance and internal control systems. It does not contain financial statements, earnings data, or detailed financial performance analysis. It is not a report such as an Annual Report, Interim Report, or Earnings Release. Instead, it is a regulatory announcement about planned capital/financing-related derivative activities to manage currency risk. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is about 3,000 characters, which is consistent with an announcement rather than a full report.
2019-12-13 Chinese
独立董事关于全资子公司收购广西大美大新旅游有限公司5%股权暨关联交易的独立意见
Governance Information Classification · 95% confidence The document is an independent director's opinion on a related party transaction involving the acquisition of a 5% equity stake in a subsidiary company. It references compliance with governance guidelines and legal procedures but does not contain financial statements or detailed financial data. The document is a formal opinion related to corporate governance and transaction approval rather than a full report or announcement of financial results. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory filing or announcement of voting results. The content aligns best with a Governance Information report detailing internal decision-making and compliance with governance rules regarding related party transactions.
2019-12-10 Chinese
关于全资子公司收购广西大美大新旅游有限公司5%股权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the acquisition of a 5% equity stake in a company by a wholly-owned subsidiary, involving a related party transaction. It includes details about the transaction parties, pricing, shareholding structure before and after the transaction, financial data of the target company, and independent directors' opinions. The document is a formal disclosure of a capital transaction and related party dealings, typical of a capital/financing update or related transaction announcement. It is not a full financial report, audit report, or earnings release. It is not a proxy, AGM material, or legal proceeding report. The document length is about 4800 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the best fitting category is Capital/Financing Update (CAP).
2019-12-10 Chinese
关于控股股东约定购回式证券交易购回的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement regarding the completion of a repurchase transaction by a controlling shareholder involving a specified number of shares. It details the transaction dates, parties involved, and compliance with relevant regulations. There is no financial report, earnings data, or management discussion. The content fits the description of a Transaction in Own Shares (POS) filing, which reports the company's or controlling shareholder's buyback or sale of shares. The document length is short and focused solely on this transaction, confirming it is not a full financial report or announcement of a report publication.
2019-12-06 Chinese
关于控股子公司山东凯盛新材料股份有限公司股票发行认购的公告
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a stock issuance subscription by a controlling subsidiary of the company. It details the number of shares subscribed, subscription price, total amount raised, and approval of the stock issuance plan by a shareholders' meeting. The document is short (804 characters) and focuses on capital raising activities through a non-public stock issuance. There is no financial report, earnings data, or management discussion. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on fundraising and capital structure changes.
2019-12-03 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.